Form 4: Modular Medical Director Philip Sheibley Granted 7,500 Stock Options

Sentiment:

Insider Transaction Report


Modular Medical, Inc. Director Philip Brent Sheibley was granted 7,500 options to purchase common stock at an exercise price of $0.68 per share, fully vested on the grant date of June 30, 2025.

Summary

  • Philip Brent Sheibley, a Director of Modular Medical, Inc. (MODD), was granted 7,500 options to purchase common stock.
  • The options have an exercise price of $0.68 per share.
  • The grant date for these options was June 30, 2025.
  • The options were fully vested and immediately exercisable on the grant date.
  • The options are set to expire on June 30, 2035.
  • This grant was made in accordance with the Issuer's Outside Director Compensation Plan.

Sentiment

Score: 5

Explanation: The document reports a standard equity compensation grant to a director, which is a routine event in corporate governance and does not inherently convey positive or negative sentiment about the company's performance or outlook.

Positives

  • The grant of stock options to a director, fully vested on the grant date, aligns the director's financial interests directly with those of the shareholders.
  • The option grant is part of a formal "Outside Director Compensation Plan," indicating a structured and transparent approach to director compensation and incentives.

Future Outlook

N/A

Industry Context

This Form 4 filing reports a routine insider transaction for Modular Medical, Inc., specifically an equity compensation grant to a director. Such grants are common practice across various industries to align management and director incentives with shareholder interests. The specific details of the grant, such as exercise price and vesting schedule, are company-specific and do not inherently reflect broader industry trends.

Comparison to Industry Standards

  • N/A. This document reports a specific insider transaction and does not provide financial results or operational metrics that can be directly compared to industry benchmarks or specific comparable companies/projects. Director compensation structures, including equity grants, vary widely across companies and industries based on size, performance, and compensation philosophies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan ReferenceThe option grant was made in accordance with the Issuer's Outside Director Compensation Plan, indicating a formal structure for director remuneration.06/30/2025Reinforces structured corporate governance regarding director compensation, aligning director incentives with shareholder value.

Stakeholder Impact

  • Shareholders: The grant of options to a director aligns the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance shareholder value.

Key Dates

DateDescription
06/30/2025Date of earliest transaction (option grant date), also the date the option became fully vested and exercisable.
07/02/2025Date the Form 4 was signed by the attorney in fact for Philip Sheibley.
06/30/2035Expiration date of the granted stock options.

Keywords

Modular Medical, MODD, Form 4, Insider transaction, Stock options, Director compensation, Beneficial ownership, Equity grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.